Instrument Inactif

Communiqués Biostage Inc Nasdaq

Actions

US41690A1060

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

13/08	Harvard Apparatus Regenerative Technology Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
13/05	Harvard Apparatus Regenerative Technology Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

12/05	Harvard Apparatus Regenerative Technology : Q1 – 2026 HBIO QUARTERLY EARNINGS PRESENTATION	PU
12/03	Harvard Apparatus Regenerative Technology : Q4 - 2025 HBIO Quarterly Earnings Presentation	PU
12/01	Harvard Apparatus Regenerative Technology : HBIO Investor Presentation	PU
06/11	Harvard Apparatus Regenerative Technology : Q3 - 2025 HBIO Quarterly Earnings Presentation	PU
11/08/25	Harvard Apparatus Regenerative Technology : Q2 - 2025 HBIO Quarterly Earnings Presentation	PU
12/05/25	Harvard Apparatus Regenerative Technology : Q1 - 2025 HBIO Quarterly Earnings Presentation	PU
08/08/24	Harvard Apparatus Regenerative Technology : Q2 - 2024 HBIO Quarterly Earnings Presentation	PU
07/05/24	Harvard Apparatus Regenerative Technology : Q1 - 2024 HBIO Quarterly Earnings Presentation	PU
18/03/24	Harvard Apparatus Regenerative Technology : March 19, 2024 - Investor Presentation	PU
07/03/24	Harvard Apparatus Regenerative Technology : Q4 - 2023 HBIO Quarterly Earnings Presentation	PU
18/09/23	Harvard Apparatus Regenerative Technology : Northland Capital Markets Institutional Investor Conference 2023	PU
08/08/23	Harvard Apparatus Regenerative Technology : Q2 - 2023 HBIO Quarterly Earnings Presentation	PU
19/07/23	Biostage Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	AQ
13/06/23	Biostage to Host Investor Call	PR
31/05/23	Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease	AQ
10/04/23	BIOSTAGE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
10/04/23	Biostage Appoints Ron Packard to Board of Directors	AQ
06/04/23	BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/04/23	Biostage Announces $6 Million Financing to Advance Clinical Trial	AQ
30/03/23	BIOSTAGE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
14/03/23	BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
07/03/23	BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
02/03/23	Biostage Announces Chairman and CEO Transition	PR
26/01/23	BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers (form 8-K)	AQ
12/01/23	BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ